首页 | 本学科首页   官方微博 | 高级检索  
     


Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global,multicentre collaboration
Authors:Praful Ravi  Gregory R. Pond  Leonidas N. Diamantopoulos  Christopher Su  Ajjai Alva  Rohit K. Jain  William P. Skelton IV  Sumati Gupta  Jonathan D. Tward  Kathleen M. Olson  Parminder Singh  Camilla M. Grunewald  Guenter Niegisch  Jae-Lyun Lee  Andrea Gallina  Marco Bandini  Andrea Necchi  Matthew Mossanen  Bradley A. McGregor  Catherine Curran  Petros Grivas  Guru P. Sonpavde
Affiliation:1. Dana-Farber Cancer Institute, Boston, MA, USA;2. McMaster University, Hamilton, ON, Canada;3. Fred Hutchinson Cancer Research Center Seattle, University of Washington, Seattle, WA, USA

University of Pittsburg Medical Center, Pittsburgh, PA, USA;4. University of Michigan, Ann Arbor, MI, USA;5. Moffitt Cancer Center, Tampa, FL, USA;6. University of Utah's Huntsman Cancer Institute, Salt Lake City, UT, USA;7. Mayo Clinic College of Medicine, Scottsdale, AZ, USA;8. Department of Urology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany;9. Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;10. Vita-Salute San Raffaele University, Milan, Italy;11. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;12. Fred Hutchinson Cancer Research Center Seattle, University of Washington, Seattle, WA, USA

Abstract:
Keywords:bladder cancer  neoadjuvant chemotherapy  pathological response  recurrence  #BladderCancer  #blcsm
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号